A case study of polypharmacy management in nine European countries: Implications for change management and implementation

McIntosh, Jennifer; Alonso, Albert; MacLure, Katie; Stewart, Derek; Kempen, Thomas; Mair, Alpana; Castel-Branco, Margarida; Codina, Carles; Fernandez-Llimos, Fernando; Fleming, Glenda; Gennimata, Dimitra; Gillespie, Ulrika; Harrison, Cathy; Illario, Maddalena; Junius-Walker, Ulrike; Kampolis, Christos F.; Kardas, Przemyslaw; Lewek, Pawel; Malva, Jo�o; Menditto, Enrica; Scullin, Claire; Wiese, Birgitt; on behalf of the SIMPATHY Consortium

doi:10.1371/journal.pone.0195232

All Outputs (5)

Quality Prescribing for Respiratory: A Guide for Improvement (2018)
Report
Respiratory Expert Group, , & Scottish Government, . (2018). Quality Prescribing for Respiratory: A Guide for Improvement. Edinburgh: Scottish Government

Quality Prescribing for Diabetes: A Guide for Improvement (2018)
Report
Diabetes Expert Working Group, , & Scottish Government, . (2018). Quality Prescribing for Diabetes: A Guide for Improvement. Edinburgh: Scottish Government

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology (2018)
Journal Article
Bousquet, J., Hellings, P. W., Agache, I., Amat, F., Annesi-Maesano, I., Mair, A., & Mobile Airways Sentinel Network (MASK) Study Group. (2019). Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology, 143(3), 864-879. https://doi.org/10.1016/j.jaci.2018.08.049

Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase o... Read More about Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

Polypharmacy Guidance: Realistic Prescribing. 3rd edition (2018)
Report
Scottish Government Polypharmacy Model of Care Group, . (2018). Polypharmacy Guidance: Realistic Prescribing. 3rd edition. Edinburgh: Scottish Government

A case study of polypharmacy management in nine European countries: Implications for change management and implementation (2018)
Journal Article
McIntosh, J., Alonso, A., MacLure, K., Stewart, D., Kempen, T., Mair, A., Castel-Branco, M., Codina, C., Fernandez-Llimos, F., Fleming, G., Gennimata, D., Gillespie, U., Harrison, C., Illario, M., Junius-Walker, U., Kampolis, C. F., Kardas, P., Lewek, P., Malva, J., Menditto, E., …on behalf of the SIMPATHY Consortium. (2018). A case study of polypharmacy management in nine European countries: Implications for change management and implementation. PLOS ONE, 13(4), Article e0195232. https://doi.org/10.1371/journal.pone.0195232

Background
Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (... Read More about A case study of polypharmacy management in nine European countries: Implications for change management and implementation.